| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | 10%+ Owner | Common Stock | 10,825,013 | $79,563,845 | $7.35 | 11 Dec 2025 | Direct |
| LEXICON PHARMACEUTICALS, INC. | Director, 10%+ Owner | Series B Convertible Preferred Stock | 367,145 | $23,864,432 | $65.00 | 02 Feb 2026 | Indirect |
| LEXICON PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock | 1,538,462 | $2,000,000 | $1.30 | 02 Feb 2026 | Indirect |
| Scholar Rock Holding Corp | 10%+ Owner | Warrant (right to buy) | 0 | 11 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | 02 Feb 2026 | 4 | +$54,984,433 | 4 | Director, 10%+ Owner | 04 Feb 2026, 16:25 |
| SRRK | Scholar Rock Holding Corp | 11 Dec 2025 | 2 | +$11,576,309 | 4 | 10%+ Owner | 06 Feb 2026, 17:35 |